Ann Gynecol Obstetr Res | Volume 1, Issue 1 | Review Article | Open Access
Edward M Lichten*
Department of Obstetrics-Gynecology, Wayne State College of Medicine, USA
*Correspondance to: Edward M Lichten
Fulltext PDFHormonal migraine is defined as the unilateral severe headaches that occur in reproductive aged women usually 7 days premenstrual to 3 days after onset of menses. This Short Commentary focuses on the fact that neurologists, major editors and pharmacists ignore and discount the facts that hormones, not pharmaceutical medications, define the cause, the biomarkers and treatment of this disease. The problems for most internists treating migraine and headaches are four-fold: they are unfamiliar with the hormonal parameters that influence migraine in both men and women, uncomfortable in prescribing male and female hormones having insignificant training in medical school, the products have been generic for more than 50 years so pharmaceutical representatives do not educate physicians in alternatives to expensive and less effective abortive medications for headaches, and only a rare physicians perform Occipital Nerve Blocks (ONB) to eliminate Tension- Type Headaches (TTH). Should any breakthrough bleeding occur, the physician treating the woman with migraine headache will need to consult with a gynecologist. The following medication protocols are readily available to prevent hormonal migraine by preventing the fluctuation in hormones at menstruation: women’s migraine can be prevented.
Lichten EM. Menstrual Migraine and Treatment Options: Review Hormonal Therapy in the Prevention of Menstrual Migraine. Ann Gynecol Obstetr Res. 2018; 1(1): 1004.